Yang H - Search Results

1

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.

Wen J, Fang S, Hu Y, Xi M, Weng Z, Pan C, Luo K, Ling Y, Lai R, Xie X, Lin X, Lin T, Chen J, Liu Q, Fu J, Yang H. Wen J, et al. Among authors: yang h. EBioMedicine. 2022 Dec;86:104371. doi: 10.1016/j.ebiom.2022.104371. Epub 2022 Nov 23. EBioMedicine. 2022. PMID: 36434949 Free PMC article.

2

Prognostic Value of a Four-miRNA Signature in Patients With Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection.

Wen J, Wang G, Xie X, Lin G, Yang H, Luo K, Liu Q, Ling Y, Xie X, Lin P, Chen Y, Zhang H, Rong T, Fu J. Wen J, et al. Among authors: yang h. Ann Surg. 2021 Mar 1;273(3):523-531. doi: 10.1097/SLA.0000000000003369. Ann Surg. 2021. PMID: 31058700

3

Lymph Node Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma: A Large-Scale Multicenter Study.

Yuan Y, Hong HG, Zeng X, Xu LY, Yang YS, Shang QX, Yang H, Li Y, Li Y, Wu ZY, Fu JH, Yao XD, Xu XE, Wu JY, Chen LQ. Yuan Y, et al. Among authors: yang ys, yang h. Ann Surg Oncol. 2019 Nov;26(12):4045-4052. doi: 10.1245/s10434-019-07601-7. Epub 2019 Jul 16. Ann Surg Oncol. 2019. PMID: 31313038

4

Comparisons of short-term outcomes between robot-assisted and thoraco-laparoscopic esophagectomy with extended two-field lymph node dissection for resectable thoracic esophageal squamous cell carcinoma.

Chen J, Liu Q, Zhang X, Yang H, Tan Z, Lin Y, Fu J. Chen J, et al. Among authors: yang h. J Thorac Dis. 2019 Sep;11(9):3874-3880. doi: 10.21037/jtd.2019.09.05. J Thorac Dis. 2019. PMID: 31656660 Free PMC article.

5

Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.

Leng X, He W, Yang H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Liu H, Yang H, Li T, Zhang X, Li Q, Wang G, Mao T, Guo X, Lin T, Liu M, Fu J, Han Y. Leng X, et al. Among authors: yang h. Ann Surg. 2021 Dec 1;274(6):e1022-e1029. doi: 10.1097/SLA.0000000000003727. Ann Surg. 2021. PMID: 31855875 Clinical Trial.

6

Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.

Chen JY, Liu QW, Zhang SS, Li JB, Yang H, Wen J, Fu JH. Chen JY, et al. Among authors: yang h. J Surg Oncol. 2020 Aug;122(2):336-343. doi: 10.1002/jso.25948. Epub 2020 May 14. J Surg Oncol. 2020. PMID: 32410255

7

Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.

Zheng YZ, Li XQ, Wang JY, Yang H, Wen J, Zhai WY, Yuan LX, Fu SS, Liao HY, Fu JH. Zheng YZ, et al. Among authors: yang h. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1956-1962. doi: 10.1016/j.ejso.2020.04.047. Epub 2020 May 4. Eur J Surg Oncol. 2020. PMID: 32439262

8

Fibrin sealant for esophageal anastomosis: A phase II study.

Lin YB, Fu JH, Huang Y, Hu YH, Luo KJ, Wang KX, Bella AÉ, Situ DR, Chen JY, Lin T, D'Journo XB, Novoa NM, Brunelli A, Fernando HC, Cerfolio RJ, Ismail M, Yang H; AME Thoracic Surgery Collaborative Group. Lin YB, et al. Among authors: yang h. World J Gastrointest Oncol. 2020 Jun 15;12(6):651-662. doi: 10.4251/wjgo.v12.i6.651. World J Gastrointest Oncol. 2020. PMID: 32699580 Free PMC article. Clinical Trial.

9

Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.

Liu S, Wen J, Yang H, Li Q, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Zhao L, Liu H, Hu Y, Liu M, Fu J, Xi M. Liu S, et al. Among authors: yang h. Eur J Cancer. 2020 Oct;138:113-121. doi: 10.1016/j.ejca.2020.08.002. Epub 2020 Aug 30. Eur J Cancer. 2020. PMID: 32877795 Clinical Trial.

10

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.

Wu Y, Chen J, Zhao L, Li Q, Zhu J, Yang H, Guo S, Xi M. Wu Y, et al. Among authors: yang h. Cancer Res Treat. 2021 Jan;53(1):172-183. doi: 10.4143/crt.2020.594. Epub 2020 Sep 4. Cancer Res Treat. 2021. PMID: 32898941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56,616 results

Search Page